Navigation Links
Nuvo Research subsidiary signs collaboration agreement with Fortune Global 500 company
Date:11/25/2008

MISSISSAUGA, ON, Nov. 25 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products delivered to and through the skin, today announced that fqubed, Inc., its San Diego-based research and development subsidiary, has signed a research and development collaboration agreement with a Fortune Global 500 company that develops and markets skin care products. Financial details of the agreement were not disclosed.

"The fqubed technologies have valuable applications beyond our primary focus on pharmaceutical products delivered to and through the skin," said Dan Chicoine, Nuvo's Chairman. "Collaboration agreements such as this allow us to leverage the power of our transdermal screening and high throughput formulation development platforms in complementary areas, and to improve our research capabilities so that we can more effectively develop our own topical drug pipeline."

Under the collaboration, fqubed will expand the scope of its TEMPEST(TM) high throughput experimentation (HTE) platform to evaluate potential formulations for its partner's product portfolio. TEMPEST(TM) is currently used to screen the impact that formulation variations have on the penetration of a drug molecule through skin. TEMPEST(TM) offers testing throughput significantly higher than conventional equipment thereby increasing the likelihood of new discoveries.

"Collaborations with leading third parties validate fqubed's HTE technology leadership position," added John M. Newsam, fqubed's President and Managing Director. "They also allow us to broaden and strengthen our proprietary HTE platforms with input from groups that have extensive and complementary experience with skin-applied products."

Nuvo acquired fqubed in 2005 to increase its ability to develop novel drug products for delivery to or through the skin. The Nuvo subsidiary has discovered molecular penetration enhance
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. UCSD researchers identify potential new drug target for chronic leukemia
2. USC researchers identify novel approach for suppressing prostate cancer development
3. Children's National Dedicates New Research Facility
4. Researchers identify new leprosy bacterium
5. CVS/pharmacy Raising Funds for the St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign to Support Expanded Rehabilitation Services Center
6. VivoMetrics LifeShirt(R) Selected by Concordia University to Provide Patient Data for Healthy Heart Research Project
7. Marlo Thomas and St. Jude Childrens Research Hospital(R) Kick Off The 5th Anniversary of the Thanks and Giving(R) Campaign Asking America to Support St. Jude While Shopping this Holiday Season
8. Collexis Launches Innovative Reviewer Finder to Enhance the $30 Billion Health Research Grant Industry
9. Smoking, teens and their parents: New research
10. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs
11. Researchers discover strategy for predicting the immunity of vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2010)... Oklahoma-based health management company partners with nationally-recognized orthopedic hospital. , ... ... Cornerstone Healthcare Partners has entered into an agreement with ... the Tower Day Surgery Center and the Orthopedic Hospital, ... is now responsible for the day to day operation of the ...
(Date:3/21/2010)... ... , , ... ... ... Today the House of Representatives passed the Senate health care bill with a multitude of abortion funding provisions and passed the reconciliation bill to increase ...
(Date:3/21/2010)... on the House floor tonight in support of historic health insurance reform legislation.  The House ... 212. That bill now goes to the President for his signature into law.  A second ... goes to the Senate.  Below are the Speaker,s remarks.   , ... ... , ...
(Date:3/21/2010)... Online dealer for used stair lifts, 4 Stair Lifts, will now buy ... working order, and sell them at discounted prices. , ... (Vocus) March ... it will now buy back used stair lifts from AmeriGlide ... longer need them, and then make sure they are working correctly before ...
(Date:3/21/2010)... ROCHESTER, Minn. -- A five-center collaborative study that scanned the ... as well as healthy never smokers has found a gene ... those cancers. , In the March 22 on line issue ... that about 30 percent of patients who never smoked and ... allele, residing in a gene known as GPC5. The research ...
Breaking Medicine News(10 mins):Health News:Cornerstone Health Corporation Named Manager of Orthopedic Institute's Hospital and Tower Day Surgery Center 2Health News:Pro-Life Movement Vows to Replace Members From Pro-life Districts Who Voted for the Most Pro-Abortion Bill Ever Passed by Congress 2Health News:Pro-Life Movement Vows to Replace Members From Pro-life Districts Who Voted for the Most Pro-Abortion Bill Ever Passed by Congress 3Health News:Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans' 2Health News:Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans' 3Health News:Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans' 4Health News:Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans' 5Health News:Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans' 6Health News:Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans' 7Health News:Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans' 8Health News:Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans' 9Health News:4 Stair Lifts Announces Used Stair Lift Buy Back Program 2Health News:Gene is linked to lung cancer development in never-smokers 2Health News:Gene is linked to lung cancer development in never-smokers 3Health News:Gene is linked to lung cancer development in never-smokers 4
... appear to curb compulsive acting out, study says , , ... Parkinson,s disease drugs called dopamine agonists can cause patients ... hypersexuality, says a new study. , Mayo Clinic ... doses of dopamine agonists, such as pramipexole and ropinirole, ...
... to allow citizens to use their own words, not government ... will is a national resource for advance care planning - ... Aging with Dignity, a national non-profit organization that ... joins with thousands of other organizations nationwide on April 16th ...
... study by Mount Sinai faculty suggests that a gene ... Alzheimer,s disease dementia cases. The research, led by Dr. ... in Neurology, and Professor of Psychiatry and Geriatrics and ... published this week in the scientific journal, Archives ...
... Trinity College Dublin published in this month,s Annals ... in the treatment of patients undergoing major cancer surgery. ... group at Trinity College Dublin and St James,s Hospital. ... as part of an oral nutritional supplement resulted in ...
... times a scientific article is cited by other articles is ... offers another measure: the number of unique downloads. , ... finds that downloads are a good predictor of citations ... was published in an editorial by Journal of Vision ...
... FRIDAY, April 10 (HealthDay News) -- Debate about the ideal age ... U.S. economy in a dramatic slump, the flip side of that ... become uppermost in many people,s minds. , As workers young and ... mortgage crisis and stock market tumbles, they joke that they,ll have ...
Other Medicine News:Health News:Parkinson's Drugs Can Trigger Unhealthy Behaviors 2Health News:Aging with Dignity Celebrates National Healthcare Decisions Day 2Health News:Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease 2Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 2Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 3Health News:Omega-3 fatty acids may benefit cancer patients undergoing major operations 4Health News:How Old Is Too Old to Work? 2Health News:How Old Is Too Old to Work? 3
(Date:3/18/2010)... PITTSBURGH , March 18 ChemImage, a ... present the results of an ingredient-specific particle sizing (ISPST) ... Respiratory Drug Delivery (RDD) 2010 ( www.rddonline.com ).  This ... 29th in Orlando, Florida and will ...
(Date:3/18/2010)... the "Company"), an international biopharmaceutical company with,operations in the U.S. and China , is pleased to announce the exercise of a,warrant by a principal shareholder, RimAsia Capital ... ... ... ...
(Date:3/18/2010)... HARBIN, China , March 18 ... One Medical" or "the Company") (Nasdaq: CSKI ... in the People,s Republic of China ... anti-cancer drug co-developed by Taiwan,Golden Biotechnology Corporation ("Golden ...
Breaking Medicine Technology:ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development 2ChemImage's Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development 3NeoStem Announces Warrant Exercise by Principal Shareholder 2NeoStem Announces Warrant Exercise by Principal Shareholder 3NeoStem Announces Warrant Exercise by Principal Shareholder 4NeoStem Announces Warrant Exercise by Principal Shareholder 5China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology 2China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology 3China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology 4China Sky One Medical Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology 5Brain Imaging Study Sheds Light on Fibromyalgia 49502 1Pages to Doctors Dont Always Hit the Mark 49499 1Pages to Doctors Dont Always Hit the Mark 49499 2Pages to Doctors Dont Always Hit the Mark 49499 3Brio Active Brings Whole Body Vibration Fitness to Cherry Hills Village 49496 1Brio Active Brings Whole Body Vibration Fitness to Cherry Hills Village 49496 2
... Data from Open-Label Study Presented at Federation ... CARLSBAD, Calif., June 11, 2007 /PRNewswire-FirstCall/ --,Orchestra ... new data from its completed Phase II ... Receptor (TCR) peptide,vaccine for the treatment of ...
... /PRNewswire-FirstCall/ -- Vion,Pharmaceuticals, Inc. announced that it ... the 12th Congress of the European Hematology,Association ... lead anticancer,agent Cloretazine(R) (VNP40101M) as a single ... trial in a subset of,elderly patients with ...
Other Medicine Technology:Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 2Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 3Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial,of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable,Cytogenetics at EHA Meeting 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 7.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 6 mm....
Medicine Products: